CSIMarket Company Name, Ticker, Competitors, else..
 
Dexcom Inc   (NASDAQ: DXCM)
Other Ticker:  
 
 

Dexcom Inc Growth Comparisons

Select each growth Category to receive further Information



DXCM Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 2 % 1.71 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) -0.99 % -0.05 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 16.19 % 3.53 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 0.5 % 0.09 % 1.78 % 1.08 %
Revenue 5 Year Average Growth 28.55 % 6.53 % 8.02 % 7.61 %


DXCM's Growth Comparisons in III. Quarter 2024




Softening Dexcom Inc 's 2% year on year Revenue improvement, in the third quarter 2024 to 994 millions, outgrows the 1.71% growth in the Medical Equipment & Supplies industry, but Dexcom Inc 's growth compares unfavorably, to the 7.3% Revenue growth in the Healthcare sector.

Top-line fell by -0.99% from the second quarter. Average annual sales growth for Dexcom Inc is 28.55%, while S & P 500's average yearly sales increase is 7.61%, including only Businesses with the third quarter 2024 financial results.

DXCM Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Distributor
0.43 %
-1.95 %
Direct
11.53 %
4.65 %
United States
-1.64 %
-4.1 %
International
11.82 %
7.31 %
Total
2 %
-1.05 %


Growth Rates of DXCM's Income in the third quarter 2024


DXCM Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) -26.03 % 185.03 % 79.88 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) -3.8 % 27.33 % 33.31 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) 24.06 % 256.41 % -5.85 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) -7.85 % 24.14 % 19.89 % 1.36 %
Operating Income 5 Year Avg. Change - -11.94 % 6.12 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 11.52 % 352.55 % 284.25 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) -6.2 % 42.14 % 118.94 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 80.58 % 585.41 % 26.21 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 2.08 % 33.38 % 56.32 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change - -14.49 % -9.76 % 7.3 %

DXCM Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 11.52 % 132.62 % 7.9 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) -6.2 % 90.6 % 132.5 % -6.89 %
Y / Y Net Income Change (Q3 TTM) 80.58 % 321.55 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) 2.08 % 29.67 % 2.5 % -1.41 %
Net Income 5 Year Avg. Growth - -10.79 % -3.41 % 7.44 %

DXCM's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 9.68 % 593.83 % 284.25 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) -5.56 % 53.42 % 118.94 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 99.62 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 1.75 % - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -26.3 % -9.76 % 7.3 %



DXCM EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 17.24 % 256.65 % 7.9 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) -2.86 % 105.72 % 132.5 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 3.12 % - - -6.16 %
EPS Net 5 Year Avg. Change - -10.79 % -3.41 % 7.44 %



Dexcom Inc improved it's EPS by 17.24% from the same quarter a year ago, in the third quarter 2024, and underperformed the 256.65% surge in the Medical Equipment & Supplies industry, but beating the 7.9% growth in the Healthcare sector. Above average income per share gains in Healthcare and Medical Equipment & Supplies industry, helped to elevate overall market growth to -6.44%.

the bottom-line fell by -2.86% from the second quarter. Average annual income per share growth for Dexcom Inc is 28.55%, while S & P 500's average yearly income per share increase is 7.44%, including only Businesses with the third quarter 2024 earnings.

DXCM Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -25.89 % -21.14 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) -28.6 % -13.87 % 107.48 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) 9.94 % -0.83 % 4.23 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) -7.82 % -5.94 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change 55.61 % 1.75 % 7 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.63 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - -82.23 % - -
Seq. Net Cash Flow Change (Q3 TTM) - -92.69 % - -
Net Cash Flow 5 Year Avg. Change - - 11.22 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 120.63 % -7.78 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) 68.23 % 1.35 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) 15.79 % -1.37 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) 26.91 % -2.45 % 2.02 % -0.5 %
Capital Expenditures 5 Year Avg. Change 28.66 % 10.29 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com